tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Luye Pharma Reports Revenue Growth Amid Profit Decline
Company AnnouncementsLuye Pharma Reports Revenue Growth Amid Profit Decline
9d ago
Luye Pharma Reports Mixed Interim Financial Results for 2025
PremiumCompany Announcements
Luye Pharma Reports Mixed Interim Financial Results for 2025
10d ago
Luye Pharma Announces Partial Conversion of Convertible Bonds
PremiumCompany Announcements
Luye Pharma Announces Partial Conversion of Convertible Bonds
18d ago
Luye Pharma Group to Review Interim Results and Dividend
PremiumCompany Announcements
Luye Pharma Group to Review Interim Results and Dividend
20d ago
Luye Pharma Completes Enrollment for Pioneering Anxiety Drug Trial
PremiumCompany Announcements
Luye Pharma Completes Enrollment for Pioneering Anxiety Drug Trial
20d ago
Luye Pharma Announces Partial Conversion of Convertible Bonds
PremiumCompany AnnouncementsLuye Pharma Announces Partial Conversion of Convertible Bonds
24d ago
Luye Pharma Converts Tranche A Bonds to Shares
Premium
Company Announcements
Luye Pharma Converts Tranche A Bonds to Shares
1M ago
Luye Pharma Group Announces Successful AGM Results
Premium
Company Announcements
Luye Pharma Group Announces Successful AGM Results
3M ago
Luye Pharma Group Announces 2025 Annual General Meeting
PremiumCompany Announcements
Luye Pharma Group Announces 2025 Annual General Meeting
4M ago
Luye Pharma Launches Rotigotine Patch in UK, Expands CNS Treatment Portfolio
PremiumCompany Announcements
Luye Pharma Launches Rotigotine Patch in UK, Expands CNS Treatment Portfolio
5M ago
Luye Pharma’s Antidepressant Ruoxinlin® Gains Approval in Macao
PremiumCompany Announcements
Luye Pharma’s Antidepressant Ruoxinlin® Gains Approval in Macao
5M ago
Luye Pharma’s Rivastigmine Patch Gains Approval in Japan
PremiumCompany Announcements
Luye Pharma’s Rivastigmine Patch Gains Approval in Japan
5M ago
Luye Pharma Reports Mixed Financial Results for 2024
PremiumCompany AnnouncementsLuye Pharma Reports Mixed Financial Results for 2024
5M ago
Luye Pharma Group Schedules Board Meeting to Approve Annual Results and Dividend
Premium
Company Announcements
Luye Pharma Group Schedules Board Meeting to Approve Annual Results and Dividend
6M ago
Luye Pharma upgraded to Neutral from Sell at Goldman Sachs
Premium
The Fly
Luye Pharma upgraded to Neutral from Sell at Goldman Sachs
6M ago
Luye Pharma Initiates Phase II Trial for CNS Drug LY03015 in China
PremiumCompany Announcements
Luye Pharma Initiates Phase II Trial for CNS Drug LY03015 in China
8M ago
Luye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
PremiumCompany Announcements
Luye Pharma’s New Antipsychotic Drug LY03020 Approved for U.S. Clinical Trials
8M ago
Luye Pharma Chairman Increases Stake, Signals Confidence
PremiumCompany Announcements
Luye Pharma Chairman Increases Stake, Signals Confidence
9M ago
Luye Pharma Announces Convertible Bond Issuance
PremiumCompany Announcements
Luye Pharma Announces Convertible Bond Issuance
9M ago
Luye Pharma Bolsters Liquidity with $50M Bond Issue
PremiumCompany AnnouncementsLuye Pharma Bolsters Liquidity with $50M Bond Issue
9M ago
Luye Pharma Gains Approval for Cancer Drug Zepzelca
Premium
Company Announcements
Luye Pharma Gains Approval for Cancer Drug Zepzelca
9M ago
Luye Pharma Gains Ground with New Drug Inclusions
Premium
Company Announcements
Luye Pharma Gains Ground with New Drug Inclusions
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >